Pacira Biosciences
PCRX
Pacira Biosciences (PCRX) - Total assets
Total assets on the balance sheet as of December 2023 : $1.57 B
According to Pacira Biosciences 's latest financial reports the company's total assets are $1.57 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Pacira Biosciences - Total assets on balance sheet (from 2009 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.57 B | -6.35% |
| 2022-12-31 | $1.68 B | -18.99% |
| 2021-12-31 | $2.07 B | 62.83% |
| 2020-12-31 | $1.27 B | 53.36% |
| 2019-12-31 | $0.83 B | 20.56% |
| 2018-12-31 | $0.68 B | 9.7% |
| 2017-12-31 | $0.62 B | 60.52% |
| 2016-12-31 | $0.39 B | 0.96% |
| 2015-12-31 | $0.38 B | 18.91% |
| 2014-12-31 | $0.32 B | 92.01% |
| 2013-12-31 | $0.16 B | 51.55% |
| 2012-12-31 | $0.11 B | -1.27% |
| 2011-12-31 | $0.11 B | 70.5% |
| 2010-12-31 | $66.56 M | 51.44% |
| 2009-12-31 | $43.95 M | -13.03% |
| 2008-12-31 | $50.54 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Omeros Corporation OMER | $0.49 B | -68.68% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Heron Therapeutics HRTX | $0.22 B | -85.87% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.12 B | -92.01% | 🇺🇸 USA |